(2R,6R)-HNKT148

(S)-Norketamine 42.1, W131

[18F]ASEM T203

[18F]FMeNER-D2 M103

1H-MRS M136, T161

22q11Ds 33.1

2-photon techniques 16.3

5-HT1A receptors W137

5-ht1b M65

5-HT2A receptor T222, W54

7q11.23 M41, M42

7-Tesla M105, T131

ABCD study M200

ABIDE T36

Abstinence M248, T247, T257, W252, W257

Abuse Liability M265, M269

Abuse Potential W157

Acamprosate M234

Accumbens W284

Acetate W263

Acetylcholine 53, 53.1, 53.3, 53.4, M68, M129, W55, W282

Acetylcholine esterase inhibitors, muscarinic receptors, dementiaM236

Acoustic Startle Response T240

Actigraphy T210

Actin Remodeling T245

Activity-Regulated Cytoskeletal Associated Protein (Arc) T230

Acute and Chronic Stress 1.2, 1.3, 20.2, 42.2, 51.1, W30

Acute Stress M86, M125, M165, M167, T32, T232, T239

Adaptive Behavior W162

Addiction 9.3, 30, 40.3, 41.1, 41.2, 50.3, 50.4, 53.2, M281, T52, T255, T271, T273, T275, W44, W238

Addiction Circuitry 23.3, 41.3, 45.3, M231, T233, T270

Add-On Treatment 51

Adenosine 10

Adenosine A2A Receptor W239

Adenosine deaminases acting on RNA M178

Adenosine Triphosphate (ATP) W83

Adjunctive Brexpiprazole T141

Adolescence 39.3, 39.4, 48, 54, M28, M29, M45, M56, M88, M230, M257, M267, M275, T87, T88, W50, W268

Adolescent 2.3, M33, M47, M98, M225, W46, W114, W199

Adolescent Alcohol M227, T234, T264, W268

Adolescent Alcohol Exposure M7

Adolescent Alcohol Use M236, W39

Adolescent Anxiety 2.1, M15

Adolescent Binge Drinking M247

Adolescent Brain and Cognitive Development Study 24, 24.1, 24.3, M34

Adolescent Depression M32, M48, T26, T136, W46, W117, W124, W125

Adolescent Development W281

Adolescent Stress T60, W121

Adolescents M228, T84

Adult 11.4

Adult Anxiety W14

Adult Hippocampal Neurogenesis W153

Adult Stem Cells T254, W212

Adult-Child Interactions T93

Advantages of the Combination of Therapies M183

Adverse Childhood Experiences (ACE) M25, T159

Aerobic Exercise W211

Affective Components of Pain 16.4

Affective Disorders M97, W71, W258

Affective Instability 46.1

Affective Neuroscience T18, T91, W99

Age Effects W277

Aggression M16, M282, T83, T216, W28, W74

Aggressive Behavior W214

Aging M3, M75, T130

Agitation M63, T216

AGN-241751 M124

Agoraphobia M6

Akt W248

Alcohol 35.2, T48, T55, T57, T176, T237, T246, T260, T285, W254, W276

Alcohol Abuse W263

Alcohol and Substance Use Disorders M35, M257, M259, M280, T227, T258, T280, W262

Alcohol Consumption T53, T225, T272

Alcohol Dependence T53, T235, T272, W277, W279, W280

Alcohol Exposure M263

Alcohol Intake W231

Alcohol Seeking M234

Alcohol Sensitivity M251

Alcohol Use Disorder M7, M261, T53, T56, T78, T240, T247, T253, W249, W258, W271

Alcohol Withdrawal W263

Alcoholism M132

Alcohol-Seeking Behavior W239

Aldehyde M251

Aldosterone W271

ALFF M100

Allopregnanolone 8.3, M242, T14

Alpha2 Adrenergic Receptors M222, T216

Alpha7 Nicotinic Acetylcholine Receptor T203

Alpha-7 Nicotinic Acetylcholine Receptor M134, T41, T188, W162

Altitude W259

Alzheimer's Disease 43.3, 53, 53.4, M4, M40, M53, M220, T253, W52

AMPA glutamate receptors 27.3, M119, T271

AMPA Receptor 20.1, M148, T271, W208

Amphetamine M240, W47, W189, W219, W281

Amygdala 17, 17.3, 45.4, 49.4, 53.1, 54, 54.3, M19, M166, M252, T8, T10, T12, T104, T135, T159, T173, T175, T234, T279, T284, W155, W283

Amygdala Ablation W167

Amygdala-Based Networks 35.1, W154

Amyloid M53

Analgesia M270, T157

Anandamide M263

Anger M169

Anhedonia 12.3, 35, 35.1, 35.2, 35.3, 35.4, 41.2, M66, M73, M91, T103, T152, W97, W252

Animal Model M270, M273, W194

Animal Research W266

ANK3 T102, T109

Anorexia Nervosa 15, 15.1, 15.2, M59, T98, T99, T101, W60, W63

Anterior Cingulate Cortex (ACC) M80, M87, T56, W62, W269

Anterior Prefrontal Cortex T195

Antibody M52, M186

Antidepressant 34.2, 42, 42.1, T31, T69, T125, W89, W96, W137, W153

Anti-Depressant T102

Antidepressant Effect M148

Antidepressant Response M2, T29, W132, W138

Antidepressants 20, M72, M76, T123

Antinociception M235

Antipsychotic M184, T44, T184, W199

Antipsychotic Medication M196

Antipsychotic Response T186

Antipsychotic Treatment M210, W201, W207

Antipsychotic Unduced Weight Gain W151

Antipsychotic-Associated Obesity M38

Antipsychotic-Naïve First-Episode Schizophrenia 25, 25.2, M203, W203

Antipsychotic-Naive Schizophrenia 25, 25.4, 29.2

Antipsychotics 25.4, 38, M217, T43, T46, T213, W184, W193, W220, W224

Anti-Psychotics W225

Antisocial 24.2

Anxiety 2, 48, 48.1, M6, M13, M22, M23, M73, M284, T8, T10, T72, T73, T78, T80, T81, T105, T155, T223, T234, W94

Anxiety Circuitry 45.3, M10, M12

Anxiety Disorders 53.2, T5, T12, W15

Anxiety State 3.4

Apathy W154

Appetite 15.3

Approach/Avoidance T81

Aripiprazole M74

Aripiprazole Lauroxil W186

Aripiprazole Once-Monthly 400 Mg (AOM 400) W184

Arousal W27

Asperger's Spectrum Disorder M170

Assessment 4, W213

Associative Learning 16.1, W79, W255

Astrocyte 26, T106, T281, W83, W152

ATAC-seq T14

A-to-I RNA-editing M178

At-Risk T132

Attachment 37.3

Attention 53, 53.3, M31, M247, T58, T87, T92, W162, W189

Attention-Deficit/Hyperactivity Disorder (ADHD) M36, T16, T18, T58, T86, T90, W29, W47, W61, W65, W156, W157

Atypical Antipsychotics T145, T180

Auditory Deficits In Schizophrenia M175, M181, T205

Auditory Hallucinations T76, W185

Auditory Short-Term Memory M173

Autism Spectrum Disorder (ASD) 11.1, 13, 13.1, 21, 26.1, 26.3, 27.1, 39.2, 43.4, 51.2, M144, M170, M216, T15, T35, T36, T82, T94, T96, T161, W33, W36, W45, W143, W215

Aversion M141

Aversive Conditioning 23.3, 48.1

Avoidance M25, T75, W283

Axons 54.1

Baby Schema T252

Baclofen W276

Balb/c mouse T96

Bariatric Surgery W62

Basal Ganglia M58, T101, W79

Basolateral Amygdala 15.1, M19

Bayesian Modeling M18

BDNF T65, T116, T146, T234, W6, W10, W175, W211

BDNF Delivery 20.2

BDNF Val66Met T116, W78

Bed Nucleus of the Stria Terminalis M284

Behavior T70, T169, T178, W226

Behavioral W108, W119

Behavioral Analysis W230

Behavioral Despair T103

Behavioral Pharmacology T59, W25

Behavioral Phenotyping 7, 7.4, M226

Behavioral Variability 6

Benserazide W225

Benzodiazepines W127

Bereavement 46.2

Beta Arrestin 7.2

Beta Arrestin 2 W153

Betahisitine W220

Biased Mu Agonists 50

Bile Acids M38

Binge Drinking M247, M277, T244, T258

Binge Eating M58

Binge Eating Disorder 15.2, M55, T97, W61, W64

Bioinformatics 11.4, W37, W59

Biomarker 12.1, 20.3, M107, M130, M150, T4, T29, T114, T136, T210, T254, W1, W16, W20, W142

Biomarkers for Risk Assessment M114, W21, W52

Biotypes 25.3, 56.3

Bipolar Depression T95, T119, W130

Bipolar Disorder 11.1, 25, 25.3, 44, 44.1, 44.4, 54.4, M68, M70, M81, M82, M85, M90, M93, M95, M104, M116, M201, T24, T109, T114, T122, T124, T126, T132, T204, W82, W90, W93, W108, W111, W114, W119, W129

Bipolar I Depression W134

Bipolar I Disorder 44.1, W130, W182

Blast M153

Blood-Brain-Barrier M52

Body Mass Index T98

BOLD Imaging 46.3

Borderline Personality Disorder 4.3, 17.3, 46, 46.1, M169, M170, M171

Brain M61, T221, W203, W162

Brain Activation 25.1

Brain Aging W2

Brain Based Markers for Depression M91

Brain Circuit 35.1

Brain Connectivity 29.2, M40

Brain Connectome 56.2

Brain Development 24, 39.1, 48.1, M49, T20, W18, W41

Brain Glucose Metabolism M261

Brain Imaging 18.1, 46.1, T190, W63

Brain Insulin Resistance M197

Brain MRI M109

Brain Networks 25.1

Brain Organoids M241, T15

Brain Stimulation W159

Brain Stress T259

Brain Structural Connectivity M135

Brain Structure 24.1, M15

Brain Transcription 44.4

Brain Volumes M250

Brainstem T48

Brexanolone 8.3

Brief Motivational Intervention T258

Bulimia Nervosa M58

Buprenorphine T259, W85, W136

Buprenorphine/samidorphan M118, T138

Buprenorphine-Naloxone T187, T243, W250

burden of Illness T113

CACNA1C W218

Calcium M146

Calcium Imaging 45.2

Callous-Unemotional 24.2

CaMKII T178, W248

cAMP Signalling 20

Cannabidiol 21, 32, T263, W32

Cannabinoid M265, T278, W146

Cannabis 18, M212, M250, M256, M262, M267, T54, W14, W146

Cannabis Dependence T255

Cannabis Use 28, M33, M142, M182, M228, M253, W14, W262

Cannabis Use Disorder M260, T84, W252

Canonical Correlation Analysis (CCA) M96

Cardiac Autonomic Tone M110

Cardiometabolic Risk W151

Care Giving T252

Cariprazine W130

Catecholamine W7

Caudate T243

Causal Reasoning W165

CB1 receptor 45.4

CBT W10, W17

Cell Adhesion Molecule M274

Central Amygdala T12, T100, T264

Central Nervous System M157, W193

Central Nucleus of the Amygdala M12, M19, T62

Cerebellum W213, W223

Cerebral Blood Flow M42, W156

Cerebrospinal Fluid M219

c-Fos M268

C-Fos-Expressing Ensembles T63, W232

Chemogenetics 9.2, 45, T168, T278, W155, W231

Child Abuse and Neglect T9

Child And Adolescent Psychiatry 33.4, 39.2, W129

Childhood Adversity 47, M39, T275

Childhood Maltreatment T9, T38, W40, W42

Childhood Trauma 54.3, M18, M107, T17, T89, T242, T244, W57

Childhood-Onset Schizophrenia 7.3, M187

Children T19, T86, W44

Children and Adolescents 2.4, 54.3, M40, M199, T95, W31, W34, W38

Chipping W260

ChIP-sequencing W35

Choice Procedure M276, T267

Cholesterol Biosynthesis T246

Choline M206

Cholinergic Anti-Inflammtory Response M112

Cholinergic System M181, 768, W49, W71

Chromatin T14, W247

Chronic Mild Stress T103, T147, T151

Chronic Pain M150, T164, T165, T249, T254, W146, W250

Chronic Pain Treatment 31, W146

Chronic Social Defeat T219, T225

Chronic Stress 53.3, M260, T80, T274, T277, W87, W194

Cingulate 6.2

Cingulo-Opercular Network M20

Circadian W86, W282

Circadian Rhythm T52, T181, W82, W274

Circuit 19, 19.4, T150

Clinical High Risk 29.1, 29.2

Clinical High Risk for Psychosis 25.1, 29, 29.3, M133, M195, M212, T194

Clinical High Risk State for Psychosis 32, M182, M191, W215

Clinical Outcome Prediction W63

Clinical Prediction T26

Clinical Predictors M59, T137

Clinical Psychopharmacology M139

Clinical Stability M184

Clinical Subtypes M202, W11, W166

Clinical Trial 12.1, 28, 32, M32, M246, T71, T119, T211, W31, W91

Clinical Trial Design T4

Clinical Trial Rating Methods W46

Clonidine T189

Clozapine W220

Cluster Analysis W203

CNS Clinical Trials M94, T213, W74, W143

Cocaine 41.1, 45, 53.2, M233, M238, M246, M252, M258, M272, T50, T60, T223, T232, T250, W97, W234

Cocaine Addiction 6.4, M274, T51, T235, T238, T245, T257, W232, W235, W236, W242, W256, W257, W260

Cocaine Reinstatement and Taking T50, W233

Cocaine Seeking 41.3, 45.3, 45.4, M264, T268, W246

Cocaine Self-Administration M278, T50, T52, T277, W230, W247

Cocaine Self-Administration and Reinstatement T59, T226, T284

Cocaine-Related Disorders T256, W264

Cognition 33.2, 56, M49, M83, M133, M180, M190, M195, M215, M236, M275, T41, T47, T58, T67, T166, T185, T188, T193, T212, T238, T255, T281, W90, W147, W150, W211, W235, W281

cognitive appraisal T75

Cognitive Behavior Therapy T92

Cognitive Behavioral Therapy 2.1, M20, M87, M161, T164, T221

Cognitive Control 2.2, M218, T191, W188, W205

Cognitive Control Network 2.1, M34, M79, T25

Cognitive Decline 29.1, M53

Cognitive Enhancement 53.4

Cognitive Flexibility 15.2, W106

Cognitive Functioning 40, 54.2, M82, T17, T71, W89

Cognitive Impairment 29.3, M234, T68, T178

Cognitive Neuroscience M77, W60, W254

Cognitive Reappraisal 46.1, 46.2

Cognitive Remediation T183

Cognitive Subtypes W125

Cognitive Training 29.4

Collaborative Cross and Diversity Outbred Mice T52

Combat PTSD 3, 3.3, M19, M283, W172

Combat Veteran 3.2, 35.2, M160, T174

Common Variant 58.1

Comorbidity T220, T244, W98, W215

Complement M69

Complement Component 4 W197

Complement Factor C4 49, 49.3

Complex Brain Disorders 43.1

Compulsive Behavior 1.4

Compulsive Models Of Drug Use M231, M233, M280

Computation 56

Computational Modeling 3.3, 18, M15, M24, T120, W171

Computational Models Of Decision-Making 3.2, T21

Computational Neuroscience 3, 5

Computational Psychiatry 3, 11.3, 18.1, 39, M37, M48, T98, W171, W190

Computerized Cognitive Training M171, M181, M190, T71

COMT gene T66

Conditioned Cues W282

Conditioned Place Preference T63

Conduct Problems 24.2

Conflict T81

Conflict Monitoring W17

Congenital Malformations T145

Connection T93

Connectivity 54.4

Connectivity-Based Parcellation T153

Connectome 29.2, T257

Connectome-wide association study M43

Connectomics M158

Context 50.4, W239

Context-Induced Reinstatement M225

Contextual Fear M284

Copy Number Variant 33.3, M41, W36

Copy Number Variation M42

Corpus Callosum T172

Cortical Circuit Function 11.1, 25, M216, T39, T181, T182, T190, T204

Cortical Dysplasia T160

Cortical Excitation-Inhibition Balance 36

Cortical GABA W178

Cortical Layers T39

Cortical Plasticity T273

Cortical Thickness 13.3, M35, M94, M200, M261, T242, W18, W172

Cortical Thinning W118

Corticosteroids M159

Corticosterone T34, T96, T103

Corticostriatal Circuit T276

Corticostriatal Networks 1

Corticotropin-Releasing Factor (CRF) 45.1, T231

Cortisol M67, T8, T133, W118, W271

Craving T241, T247, W276, W280

C-Reactive Protein T7, T95

Creativity W126

CRF M282, T13

CRF-R1 T225

CRH T108

CRISPR/dCas9 W175, W247

Cross Species W78

CRP M102, T1, T115, W138

CSF Biomarkers M153

Cue Reactivity M258, T55, T260

Cue Reinstatement W245

Cyclic AMP 20.3

CYP2D6 M74

Cytokine 26.3, M219, T105, T212, W236

cytokines 26.1

Cytomegalovirus T139

D1 Dopamine Receptors 1.3, 1.4, M174, T231, W147, W248, W270

D1/D2 1, T224

dACC 3.4

D-Amino Acid Oxidase W187

DAMPs M99

Dasotraline M55, W29, W64

Data Discovery M138

Data Quality 32

Data Sharing M138

Data Similarity M138

Database W183

d-cycloserine W134

Decision-Making 3.4, M67, M278

Deep Brain Stimulation M264, T37, W160

Deep Indexing M138

Default Mode Network (DMN) M43, M189, T197

Delay Discounting T241

Delirium M50

Delusions T204

Dementia M236, T126, W51, W52

Dementia-Related Psychosis W54

Dendritic Morphogenesis M175

Dendritic Remodeling 1.1

Dendritic Spine 43.2

Dendritic Spines 1.1, 27.1, 40.4, W140

Dentate Gyrus T2, T199, W228

Dependence W255

Depression 1, 1.2, 2, 2.4, 7.1, 8.4, 26, 26.3, 34.4, 35.3, 35.4, 42.2, 52.4, 53, 53.2, M53, M67, M68, M74, M75, M76, M77, M78, M91, M92, M98, M105, M109, M113, M120, M121, M124, M128, M129, M130, M161, M250, T8, T25, T31, T34, T67, T84, T105, T110, T119, T125, T127, T128, T131, T133, T135, T140, T142, T143, T146, T151, T190, T219, W13, W44, W86, W94, W96, W98, W122, W135, W138

Depression Inflammation Cytokine M99, T115, W76, W124

Depression Subtypes M115, T112

Depression-Like Behavior M99, T33, T102, T103

Design M127

Development 54.4, T107, W215

Developmental Neuroscience 39.2

Developmental Psychopathology 39, M46, T17, T132

Developmental Trajectories 35

Developmental Transcriptome 13.3

Deviance Detection M173

Dexmedetomidine M63

Dextromethadone T146

Diabetes W71

Diagnosis 5

Diagnostic Boundaries 25.3, M220

Diagnostic Criteria W22

Diet Induced Obesity M46

Diffusion Tensor Imaging (DTI) 25.4, M4, M93, M192, M195, T9, T177, W1, W62, W107

Diffusion Weighted Imaging 54.2, M135, M210, T153, W75

Digital Assessment 4.1, M82

Dimensional 24.3, 39, 39.3

Dimensions 19.4

Dimensions of Psychosis M220

Disability M155

DISC1 W216

Disease Mechanism 58

Disease Modeling W81

Disorders of Glutamate 12.4, 27.3, W72, W198

Disrupted-in-Schizophrenia 1 T177

Disruptive Mood Dysregulation Disorder 39.2, M93

Dissociation M21, M25, M76

Diversity 22, M202, M224, T167

DNA 11.3, M202

DNA Methylation M116, T7, T179, W16, W101, W249

DNA Sequencing M201

Dopamine 20, 35, 35.3, 35.4, M64, M122, M125, M126, M136, M211, M212, M247, M282, T22, T64, T154, T163, T263, W4, W69, W139, W149, W162, W168, W234, W242, W244, W264, W273, W282, W284

Dopamine 2 Receptor M174

Dopamine Circuitry W70

Dopamine D2 Receptors T243

Dopamine D3 Receptors 50, M235, T276

Dopamine Receptor Type 2-Expressing Striatal Medium Spiny Neuron M264

Dopamine Receptors T37, W79

Dopamine Release T45

Dopamine Transporter T174, T268

Dopaminergic System T28, W90

Dorsal Caudate W201

Dorsal Raphe Serotonin Neurons M66, T80

Dorsal Striatum 16.3, T22, T46

Dorsolateral Prefrontal Cortex W62, W270

Dose Reduction T43

Dose-Response Analyses T35

Doublecortin W153

DREADD 35.1

DREADD Receptor T10

DREADDs 41.3, T48

Drinking T48

Drug addiction 23, 23.4, T230, T282, W269, W274

Drug Cues T250

Drug Discovery 12.2, W278

Drug Discovery - New Approaches 7, 7.2, 31.2, W147

Drug Discovery/Development 55, M274

Drug Discrimination M269

Drug Relapse 16.1, 50.4, M268, T266

Drug Response M142

Drug Side Effects M84, W192

Drug Use W272

D-Serine W187

DSM-5 W22

DTI M95

Dynamic Causal Modeling M188

Dynamic Connectivity M248

Dynorphin T154, T157, T232

Dysbiosis 51.4

Dyslipidemia M217

E/I Imbalance T109

Early Adolescence M17

Early Development 54.1

Early Identification of Risk M37, M44, M227

Early Illness Schizophrenia M191, M193

Early Intervention T71

Early Life Adversity 51.1, M1, M39, M227, T108

Early Life Stress 37.1, 47, M5, M29, M260, T83, T108, T139, T159, W30, W35, W41, W258

Early Phase Drug Development 7.3, 12.1, 55

Early Psychosis 32.1, M194, M200, M218, W207

Eating Disorders M56, M59, W60

Ecological Momentary Assessment 4.2, W272

ECT 19, 19.1, 19.4, M109, W83

EEG 10.2, M155, M156, T85, T178, W13, W48, W141, W226

EEG Biomarkers T51

EEG Synchronization 10

EEG/ERP Electrophysiology T121, T189, W180, W191

Efficacy M55

Effort Based Decision Making Task W65

Effort Choice Task T210

Effort Discounting T201

eIF4E 31.1

Electrical Field Modeling M109, T153

Electroconvulsive Therapy 19.2, 19.3, M162, T28, T134, W120

Electroencephalography M50, M158, T172

Electronic Health Record (Ehr) T208

Electronic Medical Record W73, W173

Electronic Prescribing Warnings M139

Electrophysiology 45.1, M126, M278, T12, T80, T191, W70, W140

ELISA T99

Emergency Medicine W21

Emotion 48.4, T89, T133, T255

Emotion Modulation W158

Emotion Processing 6.4

Emotion Recognition W257

Emotion Regulation 17.3, 46.2, M218, T18, T26

Emotional Processing W103

Emotional Regulation M171, W108, W119

Emotional Response Inhibition M45

Emotional Stress M28

Empathy 9, 9.2, 9.3, W126

Endocannabinoid System 32, M169, M260

Endocannabinoids 31.3, 32.1, M167, T79, T163, T277

Endophenotypes 7, M220

Energy Metabolism M133

ENIGMA Working Group T104

Enkephalin T157

Entropy W176

Environment W260

Environmental Risk Factors W259

Epidemiology M137

Epigenetic Modification M236, M244, W101

Epigenetics 13, M107, M172, M240, T65, T179, T233, T234, T264, W16, W35, W42, W67, W78, W242

Epigenome 11, T162

Epigenomics 52

Epilepsy 27.1, M130, T160, W141, W167

Epiodic Memory T66

EPMS M196

eQTL 44.4, T207

ERK M28, M238

ERP W163

Error Processing M209, W163

Escitalopram M2, M74, M91

Esketamine 42.1, M76, M269, T125, W131

Estradiol M97, M108, M125, T66, T74

Estrogen Receptor T185

Ethanol M131, M277, T62

Ethical Issues M137

Ethics 28, 57, T166

Event-Related Potentials M35, T194

Evidence-Based Approach W183

ExcitabilIty T20

Excitatory Synapses 27.1, 27.2

Executive Function W33

Exercise 15.4

Exosomes M237

Exosomes of Neuronal Origin M197

Expectation Bias T260

Experience M185

Experimental Medicine 12.1

Experimental Therapeutics 12.4, M79, T156

Exploration 3.4

Explore-Exploit Dilemma T21

Exposure T94

Exposure therapy W170

Expression M185

Extended Amygdala M8, T13

Extended-Release Depot M184

Extended-Release Naltrexone M245, T248, W250, W253

Externalizing Disorders M39

Extinction learning T284, W10

Extinction Memory Recall T5, W171

Extracellular Matrix 49, 49.4, T49, W87

Extracellular Vesicles M237

Eye-Tracking W38

F-18 PET Imaging 27.3, M261, W92

FAAH M263

Face Emotion Processing T91

Facial Emotion Processing M191, W24

Factor Analysis W213

Fast Scan Cyclic Voltammetry W273

Fast-Acting Antidepressant W133

Fatty Acid Amide Hydrolase M169

Fatty Acids M49

Fear T12, W6, W18

Fear Conditioning 1.2, 48.2, 48.4, M5, M7, T70, T75, T79, T107, T173, W226

Fear Extinction M7, M167, T5, W8

Fear Generalization M117, T154

Fear Memory M9, W9

Feed Forward Inhibition T270

Feeding T168

Feeding Behavior 15, 15.2

Female 42.2, T169, T225, W28, W97

Fentanyl M232, T267

Fetal Alcohol Syndrome M244

Fetal Brain Development 58.4

Fetal Programming W57

First Episode Psychosis M221, T186, W201, W213, W227

First Episode Schizophrenia M187, T209

First-Episode Psychosis T208

FKBP5 W20, W30, W42

Flanker Task T121

Fluorodeoxyglucose M160, M211

Fluoxetine 1.4, T34, W28, W97

fMRI Biomarkers 12.4, 25.1, M27, M88

fMRI Effective Connectivity T91

fMRI Functional Connectivity 29.3, M257, W104

fMRI Negative Affective Stimuli W57

fMRI Resting State M245

Folate 13

Folic acid 13.1, 13.3

Food Addiction T97, T285, W232

Food Intake 15.4

Forceps Minor W75

Forgetting W9

Fractional Anisotropy W56

Fragile X Syndrome M146, M149, T85, W32

Frontomedial Negativity M193

Frontoparietal W158

Frontostriatal Circuitry M135

Frustration W106

Frustration Tolerance T18

FTO T19

Functional and Structural MRI W167

Functional Capacity 25

Functional Characterization 58

Functional Connectivity 24.1, M100, M142, T42, W202

Functional Genomics 11.3, 11.4

Functional MRI (fMRI) 2.2, 3.2, 12.1, 12.3, 15.4, 18.1, 29.2, 35.3, 40.3, 41.2, 46.1, 46.2, 48, 48.4, 56.3, M16, M34, M44, M45, M56, M57, M79, M91, M96, M142, M161, M165, M188, M189, M207, M209, M249, M252, M256, M258, M260, M262, T16, T36, T37, T54, T55, T59, T66, T69, T72, T129, T135, T175, T190, T201, T221, T240, T248, T250, T252, T255, T258, T260, W5, W17, W19, W34, W38, W61, W62, W63, W99, W103, W106, W108, W109, W119, W176, W205, W218, W256, W266, W269, W275

Functional Neuroimaging M17, T88, T89

G Protein 20.3

G Protein Coupled Receptors 43.3

G Protein Signaling 43.3, M239

G Protein-Coupled Receptors 7.2

G9A T223

GABA 8, 8.2, 8.4, M65, M162, T14, T15, T48, T109, T148, T161, W135

GABA Transmission W279

GABA-A Receptor Positive Allosteric Modulator 8.3, 8.4, W148

GABA-A Receptors M215, T161, T182, W140

GABAB T270

GABA-B receptors W276

GABAergic Interneurons 10.4, M216, M223

GABRA6 M132

Gait speed W4

Galantamine W222

Gambling Disorder T239, T251

Gamma Oscillation 34, 34.4, 36, T163, T217

Gender M131

Gender Differences 42

Gender Identity 24.3

Gene Environment Interaction W41

Gene Expression 44.3, M12, M13, M131, T60, T112, T181, W231

Gene Transcription T179, W175

Genecept Assay M147

Genetic Animal Model W231

Genetic Association 58

Genetic Association Study M187, W197

Genetic Liability T191

Genetic Mouse Model W178

Genetic Risk 43

Genetic Score W37

Genetic Testing 57

Genetic Variability M18

Genetic Variation W216

Genetics M201

Genome-Wide Association Study 44, 44.1, 44.4, M201

Genomic 33, 52.4

Geriatric T69

Geriatric Depression M2, W95

Ghrelin 15.3, W271

Glia 26.1

Global Assessment of Functioning (GAF) T114

Globus Pallidus T42

GLT-1 T279, W245

Glucocorticoid Dysregulation 23.4, W30

Glucocorticoid Receptor 23.4, M70, W249

Glucocorticoids M1, T277

GluN2B 34.2

GluN2C subunit W223

Glutamate 12.2, 20.2, 49, M1, M71, M90, M136, M234, T106, T148, T215, W55, W201, W245

Glutamate GABA 34, 34.2, T127, T205

Glutamate Homeostasis T279, T281

Glutamate Receptor Function 20, 27, 43.4

Glutamatergic Synapses 20.2

Glutamatergic Transmission M121

Glutamine T127

Glutathione (GSH) W200

Goal-Directed Behaviors W239

Goal-Directed Control T261

Gonadal Hormones M9, T23

GoNoGo M252

GPCR 20, 20.3, W278

Graph Theory 19.2, T101

Graph-Based Analysis W176

Gray Matter Volumes T242

GSK3 W246

GSSG W200

Guidance Cues W37, W281

Gut Microbiome 51, 51.1, M38, T105, T221

Gut-Brain Axis 51.4, T221

GWAS 44.1, 58.2, T53, T162, T166, T199, W195

GWAS LOCI M274

habenula M101, M249, W104

habit M67, T22, T237

habit formation T64

habits 6.2, W60

habituation M221

hallucinations T204

Hallucinogen M226, T222

HCN M123

HDAC W145

HDAC inhibitors W231

Health Policy 28

Health-Related Quality Of Life 8.4

Healthy Individuals M62

Healthy Subjects M255

Heart Rate Variability M171, T241

Heat Shock Protein 70 T32

Hemodynamic Response Function M165

Heroin Self-Administration T49, T224, T282

Herpesvirus T139

Heterogeneity W22

Hierarchical Clustering 56.3, M115

High Risk M90

High Throughput Screening 7.4

High-Throughput M51

Hippocampal Shape W118

Hippocampal subfields M159, T131, T253, W39, W120, W182

Hippocampal Volume M92

Hippocampal-Prefrontal M223

Hippocampus 1.2, 16.2, 19.1, 27.2, 45.4, M68, M72, M98, M121, M129, M163, M167, M253, T104, T110, T186, T195, T199, T253, W228

Hippocampus-mPFC Pathway 40.1

hiPSC 44, 58, 58.2, W81

Histone W242

Histone Deacetylase T224

Histone Methylation T223

HIV T159, W251

HIV-Associated Neurocognitive Disorder M230, M241

Hoarding Disorder W11

Homeostasis 10

Homeostatic Plasticity 34.4

HPA Axis 23.4, 37.1, 52.3, M70, T8, W20, W41, W67, W121

Human 19

Human Brain 11

Human Brain Imaging 18, W263

Human Clinical Trial M181, W113

Human Connectome T153

Human Genetics 33, 57, 58.3, 58.4, M201, T53, T167, W15, W173, W218

Human Imaging M75

Human Laboratory Study T79

Human Neuroimaging 24, 29, 33, 35.4, 46, 46.3, M105, M250, T128, T251, W172, W268

Huntington's Disease W74, W145

Hydroxynorketamine 20.1, 42.1, 42.2, M121, M127, T31, W131, W133, W135

Hyperarousal M10

Hypersexual Disorder W67

Hypertension M143

Hypobaric hypoxia W259

Hypocretin T13, T226

Hypothalamus M6, M166, M244, T108, T180

IL-1b M186

Imaging M98, M133, T73

Imaging Genetics T249

Immediately Early Gene M73

Immobility T96

Immune 35, W197

Immune Biomarkers T238, W56

Immune Dysfunction 51.2, T139, W261

immune Markers 26.1

Immune Responses W216

Immune System M157, M275

Immunopharmacotherapy 50.2

Impulse Control 6.3

Impulsiveness 6

Impulsivity 30, 39.4, M62, M64, M65, M254, T56, T261, W69

In Vitro Neuronal Differentiation M146

In Vivo W148

In Vivo Calcium Imaging 15.1, 16.2, 16.4, 40.2, 40.4, M10, M280, T2, T46, T63, T272, W27, W228

In Vivo Imaging 16

In Vivo Microscopy 1.4

Incubation of Cocaine Craving T274

Incubation of Craving for Cocaine And Nicotine M229

Incubation of Drug Craving M272, T51

Individual Differences M231

Induced Pluripotent Stem Cells (iPSCs) 7, 7.3, 44.3, 58.1, 58.3, 58.4, W192, W196, W212

Infancy M5

infant 39.1, 54, W56, W57

Inference and Learning W171

inflammation 35.3, M83, M89, M113, M150, M186, T1, T32, T47, T115, T140, T212, T254, W7, W42, W138

Inflammatory Pain 23.2

Informatics 7.4

Information Processing W189

Infralimbic Cortex T106

Infrared M156

Inhibition 16.2, M216

Inhibitory Control M281

Innate Immunity M99

Innovative Methods 40

Insight W11, W269

Insula 9.2, 15.1, M57, T129, W57

Insular Cortex M21, T100

Insulin M106, T180

Insulin Resistance M1, M107, W193

Interactomes 43.1

Intergenerational Transmission 48, 48.3

Interleaved TMS/fMRI M80, W158

Interleukin 1beta M157

Interleukin-1 W279

Internalizing Disorders M39

Internet W44

Interneurons 40.1

Interoception 6.4, M23, M59, T129, W94

Interoceptive Awareness M59

Interpretation Bias T120

Intestinal Microbiome W124

Intracranial EEG M130

Intracranial Self-Administration T264

Intracranial Self-Stimulation M66

Intranasal Esketamine T116, T118, W89

Intranasal Ketamine W45

Intravenous Drug Self-Administration M235, T233

Intrinsic Connectivity 46.3, T25

Intrinsic Functional Connectivity T36

Ion Channels 7.1, M51

Irritability M93, T18, W38, W74, W106

ISI W180

Journal Function W164

Juvenile M67

Kainate Receptor T70

Kappa Opioid Receptor 23.2, T147, T154, T232, W136, W277

Kappa Opioid Receptor Antagonist 12, 12.3, T187, W168

Kappa Opioid Receptors M140, T268

Ketamine 20.1, 20.2, 34, 34.2, 40.4, 42, 42.1, 42.2, M32, M71, M76, M77, M106, M117, M120, M121, M122, M123, M127, T31, T32, T119, T125, T143, T144, T148, W10, W23, W45, W96, W103, W104, W109, W127, W133, W135, W137, W223

Kinase 43

Kinome W181

Knock-in mouse W278

Kynurenic Acid M180, T215, T218

Kynurenine M180, T215, W225

Kynurenine Pathway T218

Language M189

Large Scale Networks M245, W159

Late-Life Depression M94, M108, M112, W1, W4, W150

Latent Class Analysis W254

Lateral Habenula 34, M28

Lateral Hypothalamus T13, T168

Learning W162

Learning Disability M164

Leptin M46

Lethality Studies 50.2

Leukemia Inhibitory Factor (LIF) W83

Levomilnacipran M94

Light Therapy W86

Likelihood to be Helped or Harmed W186

Lipid Rafts 20.3

Lipids M26

Lisdexamfetamine W64

Lithium T122, T124, W82, W129

Lithium Response T109, W111

Lithium Treatment M104

Local Field Potentials T176, T285

Locomotor Activity M240

Locus Coeruleus M63, M222

Long Access Self-Administration 23.3, W248

Long Non-Coding RNAs T110

Long Term Depression T284

Long Term Potentiation M167, T156, T173

Longitudinal 46.2, W16

Longitudinal Analysis 35.2

longitudinal imaging 39.3, T131, W34, W39

Longitudinal Multimodal Imaging W179

Longitudinal Study T51, T114, W260

Long-Term Safety T184

Long-Term Treatment T124

Long-Term Treatment of MDD T141

LSD T80, T222

Lurasidone T95, W134

M1 and M4 Muscarinic Receptors T45, W51

Macaque Monkey M173

Machine Learning 11.4, 19.2, 39.3, 54.2, M27, T98, T129, T162, T175, W73, W117, W125, W173

Machine Learning Classification M4, M93, M101, T208, W40, W202

Machine Learning Clustering M48

MADRS W85

Magnetic Resonance Imaging T19, T130, W31, W107, W201

Magnetic Resonance Spectroscopy M197

magnetoencephalography T28

Maintanance 38

Major Depression 46, M123, T130, W95, W118

Major Depressive Disorder (MDD) 8.4, 15, 15.3, 19.1, 19.2, M14, M79, M80, M84, M87, M88, M100, M102, M103, M110, T32, T104, T106, T113, T118, T123, T138, T139, T144, T249, W5, W85, W87, W103, W104, W107, W109, W125, W127, W252

Maltreatment M98

MAPK W248

Marijuana M262, T263, W49

Marijuana Policy T263

Mass Spectrometry M205

Maternal T94

Maternal Behavior M5, T259

Maternal Depression 39.1

Maternal Immune Activation 39.1, M30, M60, T176

Matrix Metalloproteinase-9 (MMP-9) T49

MCU W241

MDMA W23, W24

MDPV M233

Mechanism of Action 31.2

MeCP2 W48

Medial Amygdala T60

Medial Forebrain Bundle W160

Medial Geniculate Nucleus T284

Medial Prefrontal Cortex 34.2, 40.2, 40.4, M21, M174, M213, M280, W27, W50, W69, W84, W87, W277, W279

Medial Septum M129, W70

Medication Adherence M208

Medication Assisted Treatment M266

Mediodorsal Nucleus of the Thalamus 49.4

Medium Spiny Neuron 1.1, M119, T49

Melatonin 31.2

Memantine M2, M159

Memory M159, M262, T72, W162

Memory and Learning 16.2, 48.1

Memory Encoding and Retrieval 45, M250

Memory Enhancement M3

Memory Function M1, M197

Memory Reconsolidation 45, 45.4, W9, W246

Menopause M108, T66, W5

Mental Health 24.3

Mental Pain T129

Mentalizing W256

Mesocorticolimbic T33

Mesolimbic Circuitry M58

Mesolimbic Reward Circuitry M228, M277

Meta-Analysis M44, T16, T187, W222

Metabolic Side-Effects W199, W207

Metabolic Syndrome T7, W225

Metabolism W263

Metabolites M120

Metabolomics M26

Metabotropic Glutamate Receptor W262

Metabotropic Glutamate Receptor 2 (mGluR2) M107, T280, W221

Metabotropic Glutamate Receptor 3 (mGluR3) W221

Metabotropic Glutamate Receptor 5 (mglu5) T59

Metalloproteases 49.4

Methamphetamine M245, M255, W24, W270

Methodologies T211

Methylation 13

Methylphenidate W29, W65, W157

Mexican Americans T123

mGlu 2/3 Receptor T31

mGlu2/3 Antagonist W137

mGluR2/3 Agonist 12

mGluR5 M14

mGluR5 Receptors 49.2

Mice T82

Microbiome 51.4

Microbiota 51.2

Microbiota-Gut-Brain Axis 51.1

Microdialysis W47, W69, W131

Microglia 26, 49.3, M69, T44, T108, W1, W92

Microglial Activation T254

MicroRNA M237, T3

Midline Theta Frequency T191

Migraine T158

Mild Traumatic Brain Injury M160

Mind & Body Approaches T220

Mindfulness M23

Miniscope W283

Minocycline T85, W31

miRNA W153

Mismatch Negativity M173, T39, T156, T183

Mitochondria M72, T235

Mixed Manic Symptoms W130

MMN T183, W180

MNK 31.1

Mobile Health T24

Mobile Technology 4, T158

Models 30

Molecular Genetics 7, T167, W82

Molecular Imaging T202

Molecular Mechanisms 12, 19.3, T230, T233

Molecular Neuroscience 52

Monetary Reward T165, T248, W13

Monoamines T65, W132

Monoclonal Antibodies 50.2

Monozygotic W196

Mood 27, T155, W121

Mood and Anxiety Disorders 3, 37.1, 53.1, M126, T158, W139, W217

Mood Disorder 7.1, M83, M89, M114, M224, T111, T120, T134, T152, W91, W92, W100

Mood Disorder Subtypes W125

Morphine W244

Morphology T251

Mortality M50

Motivation M140, M282, T45, T168, T201, W190, W230

Mouse Behavior 53.1

Mouse Genetics T52

Mouse Model 15.2, 40.2, M13, M162, M172, M232, T70, T222, T245, W226

Movement Disorders T170, T171

mPFC M141

MR Imaging W199

MR Spectroscopy M21, M262, T205

MRI 13, 19, 19.4, 39.3, M155, T245, W66, W264

mTOR M106, M272

mTORC1 31.1

Multiplex Families M201

Multi-Triggered Relapse M229

Mu-Opioid Receptor T34, T125, T157, T202

Muscarinic Acetylcholine Receptor 53.4, M183

Muscarinic Receptors M236

Mutation 33.2

Myelin 54

Myelin Imaging M41

Myoinositol M206, W100

N-Acetylaspartate W198

N-Acetylcysteine 2.3, M180

NADPH oxidase 10.4

Naltrexone T187, W253

Natural Language Processing (NLP) T208

Negative M185

Negative Affect 23.2, T79

Negative Allosteric Modulator T59

Negative QT Study M118

Negative Reinforcement 23.3

Negative Symptoms M202, T210, W190

Neonatal W58

Nest-Building T147

Network Based Statistic (NBS) T77

Network-Analysis T29, T235

Neural Circuitry 15, 29, 54.4

Neural Circuits M65

Neural Heterogeneity 41

Neural Oscillations W227

Neural Plasticity 16

Neural Progenitor Cells M146, W36

Neuregulin-1 W178

Neurexins W174

Neuroanatomy M81

Neurobehavioral Disorders 33

Neurochemistry M206, T265

Neurocircuits 41, T111

Neurocognition M253, W165

Neurocognitive Functioning M155, M187

Neurodevelopment 26.1, 26.3, 54.2, M143, T91, T182, T245, W55, W179

Neurodevelopmental Disorders 7.3, 14, M30, M37, M42, M144, M241, T97, W59, W212

Neuroeconomics 18.1

Neuroendocrine responses M165

Neuroendocrinology M108

Neuroepigenetics T50

Neurogenesis Enhancers 58.4, W9

Neurogenetics 33.3, 33.4

Neuroimaging 2, 33.4, 39, 56, T78, W154

Neuroimaging Biomarkers 2.4, 12.2, M94, W117, W207

Neuroimmune W236

Neuroimmune Activation M244

Neuroimmune Mechanisms W179, W279

Neuroimmunology M60, T130, W59, W230

Neuroinflammation 26, 51, M51, M283, T44, W152, W267

Neurological Soft Signs M196

Neuromelanin W264

Neuromodulation 16.3, 17, 40.3, M47, M156

Neuronal Activity W6

Neuronal Ensemble 37.3

Neuronal Nitric Oxide Synthase 10.2, T173, W71

Neuropathic Pain 16.4, 31, 31.1, 31.2, 31.3

Neuropathology M153

Neuropeptides M205

Neuropharmocology T172

Neurophysiology 36, W21

Neuroplasticity 29.4, M72, W141, W262

Neuroprotection M2

Neuropsychiatric Disorders 14, 16, 43, T162

Neuropsychiatric Symptoms (NPS) T159

Neuropsychology T38, W95

Neuropsychopharmacology W164

Neuroscience Training 22

Neurosteroid 8, 8.2, 8.3, M242

Neurostimulation M109, W33

Neurosurgery T160

Neuroticism T127

Neurotransmitter Co-Release W55

Neurovascular Coupling M165

New Technology 52

Next Generation Sequencing M132

N-Glycosylation M179

NGR/p75 M175

Nicotine M230, M237, T58, W55, W245, W255

Nicotine Addiction M249, M275, T283, W163, W243

Nicotine Dependence T242

Nicotinic Acetylcholine Receptors 53.1, T87, W162

Nicotinic Receptors W282

Nitrites M217

NKCC1 W178

NMDA Antagonists T146, W211

NMDA glutamate receptors 27.1, 49.2, W243, W246

NMDA Receptor 20.1, 34, M124, T156, T217, W84, W134, W142

NMDA-R antagonists W223

nNOS 10

NODDI T177

Non Human Primate 37, M235, T37, W179, W188

Non Pharmacological Interventions T24

Non-Coding DNA 11

Noncoding RNA 11.1

Nonhuman Primate Models 37.2, 54.1, M29

Non-Suicidal Self-Injurious Behavior 2.3

NOP Receptor Antagonist W25

Noradrenaline T4, T10

Norepinephrine M122

Norepinephrine Transporter Gene (SLC6A2) T90

Nosology W22

Novel Antidepressant T147

Novel Targets 31

Novel Therapeutics 50.3, M23, W142

Novelty Response M221

NR2B Receptor W135

NRXN1 58.1

Nuclear Factor Kappa B W245

Nucleus Accumbens 1.1, 1.2, 1.3, 12.3, 35.1, 45.3, M119, T50, T163, T219, T230, T248, T270, T282, T285, W87, W243, W273

Nucleus Accumbens Shell 45.1, M264, T280

Number Needed to Harm W186

Number Needed to Treat W186

Nutrition M49

Obesity 15, 15.4, M95, M217, T19, T100, W62, W122

Observational Learning 48.2

Obsession W166

Obsessive-Compulsive Disorder (OCD) 1.4, 2.2, 6.2, 40.2, M20, M25, M147, T65, T77, T92, T97, W10, W17, W31, W66, W160, W165, W166

Obsessive-Compulsive Disorder (OCD) Phenotypes M147

Obsessive-Compulsive Symptoms 1

Olanzapine M182, W220, W224

Older Adults T67

Olfaction W150

Olfactory T2

Omega-3 Fatty Acids M71, T107

Open Chromatin 58.2

Open Neuroscience M138

Opiate Addiction 6.4, M268, M274, T243, W275

Opiate Epidemic M268

Opiates 9.2, M270

Opioid 18, W283

Opioid Abuse M266, M271, M276, T267, W152

Opioid Addiction 18.1, M232, M235, M266, T241, T248, T257, W259, W260, W266

Opioid Agonist Treatment 50.4, M266, T252

Opioid Antagonist Treatment M276, T269, W224

Opioid Dependence 9, 23, 23.3, 23.4, M270, M271, M273, W250

Opioid Epidemic- Novel Approaches 9, 31

Opioid Overdose T269, W253, W259

Opioid Receptors T269

Opioid Tolerance M271

Opioid Treatment T259

Opioid Use Disorder T262

Opioid Withdrawal W241

Opioids 16.4, 23.2, 50, 50.3, M265, T157

Optogenetics 45, 45.1, M264, T22, T39, T62, T168, W155, W239, W284

Orbitofrontal Cortex (OFC) M8, W57, W155, W165

Orexin T13, W15

Orexin Receptor Antagonist M268, T226

Orexin System T40, T283

Orphan Receptors 21

Oscillatory Activity 36, T151

Outcome T262

Ovarian Hormones T169

Overeating T97

Oxidative Phosphorylation M177

Oxidative Stress W72

Oxytocin 37.2, M207, T35, W19

Oxytocin Receptor W233

P2X7 26, 26.3, W91, W92, W113

P300 T194, T205

Pain 23, W148, W168, W283

Pain Analgesia 18

Pair Bond M163

Panic M6, W15

Panic Attacks M13

Parabrachial T62

Paranoia M194

Paraventricular Nucleus of the Thalamus 45.1, 45.2, 45.3, T40

Parent - Child Dyads 48.2, 48.4

Parvalbumin Interneurons 10.4, M223, T20

Parvalbumin Neurons 40.1, M177, W50

Pathophysiology T65

Pathway Analysis W75, W261

Pattern Recognition Receptors M99

Pavlovian Conditioning M280, T100

pCREB W241

Pediatric 2, T92

Pediatric PTSD 48.3, W40

Peptidomics M205

Perceived Stress W272

Perception W63

Perceptual Learning T193

Perfusion M42, M45

Periaqueductal Grey (PAG) W241

Perimenopausal Depression M108

Perinatal Stress W58, W59

Peripheral Biomarker M89, T140, T209

Persecutory Ideation M194

Personal and Social Performance (PSP) T114, W184

Personality 39.4, M114

Personalized Medicine M147, T124

Pesticides M144

PET Imaging Study T256

PET Probe W208

PFC M275, W75

Pharmacodynamics W219

Pharmacoegenetics M74

Pharmacoepidemiology T94

Pharmacogenetic Response M84

Pharmacogenetics T123, W82

Pharmacogenomic-Guided Treatment Recommendations M84

Pharmacogenomics M147, W151

Pharmacokinetic and Pharmacodynamic W187

Pharmacokinetics T86, W51, W221

Pharmacology M85, M215

Pharmacotherapy M270, M273, W23

Phase 1 W51

Phase III Trial 55

Phenotypes 4.1, 4.2, 4.3

Phenotypic Screening W81

Phenotyping 5

Phosphorylation 43, 43.1, 43.2, 43.3, 43.4

Photometry M64

PI3K M272

Placebo Response T142

Plasma Membrane Monoamine Transporter W132

Pluripotent Stem Cells W181

Polydrug Use T265

Polygenic Risk Score M199, M203, T135, T196, W156, W195

Polygenic scores T166, T167, W214

Positive Allosteric Modulator M147, M148

Positive and Negative Syndrome Scale M184

Positive Symptom Factor M186

Positron Emission Tomography (PET) M14, M103, M160, M212, T203, W267, W270

Positron Emission Tomography (PET) Imaging 27, 32.1, M53, M97, M104, M134, M169, M211, M215, T37, T41, T68, T161, W113, W219

Post Traumatic Stress Disorder (PTSD) 3.2, 35.2, 46, 46.3, 48, 54.3, M7, M14, M16, M18, M21, M26, M27, M70, M92, M117, M134, T1, T4, T7, T9, T38, T71, T76, T79, T173, T174, T175, T262, W7, W8, W9, W12, W20, W21, W22, W23, W25, W27, W167, W170

Postmortem 43.2, T206, T271

Postmortem Brain Tissue 44.3, 52.4, M116, M177, T126, T179, W182

Postmortem Human Brain 44, 58.4, T207

Postpartum M126, W121

Postpartum Depression 8, 8.2, 8.3, T259

Potassium ATP channels W193

Potassium Channel W100

PPI T91

Prairie Voles 37, 37.3, M163

Pramipexole W90

Prazosin T4

Precision Medicine T167

Precision Medicine for Depression W4

Preclinical M276

Preclinical Alzheimer's Disease M52, W2

Prediction 2.3, 25.1, 33.2

Prediction Error M193

Predictive Models W73

Predictor Of Treatment Response W120

Predictors of Response M20

Prefrontal Cortex 40, 54, M166, M212, M234, T20, T21, T87, T279, W101, W188, W233

Pregnancy 13.1, M85, M143, M200, T145, T227

Prelimbic T272

Premenstrual Dysphoric Disorder W78

Prenatal M49, T166, T215

Prenatal Exposure 13.3, M60, T218, W49, W56

Prenatal Infection M60

Prenatal Stress M172

Prenatal Stress-Immune Model W57

Prescribing M139

Prescription Opioids 23, 41.2, W229

Prevalence W14

Prevention of Relapse by Voluntary Aerobic Exercise M229

Primary Auditory Cortex M173

Probabilistic Reward Learning T21

Processing Speed W4

Prodrug W157

Proenkephalin T34

Progesterone M97

Pro-Inflammatory Cytokines M112

Proof of Mechanism 12.3

Protein Conformations W174

Protein Dynamics W174

Protein Insolubility M176

Protein:Protein Interactions 49.2, M51

Proteomics 43.2, M13, M72, W238

Proton Magnetic Resonance Spectroscopy M90, T56, T247

PSD 43.1

Psilobybine W23

Psilocybin W99, W126

Psychedelic Medicine T143, T222, W99, W126

PsychENCODE 11, 11.4

Psychiatric Disorders T145

Psychometric Tests W2

Psychomotor Speed M251, T212

Psychophysiology T241, W167, W170

Psychosis 5, 24.1, 33.1, 56, M133, M182, M208, M219

Psychosis Continuum 56.2

Psychosis Risk M199, M209

Psychosocial Stress T96

Psychosocial Treatment T84

Psychosomatic Medicine T220

Psychostimulant T266

Psychotherapy 46, 46.3

Psychotic Disorders M224, T41, T47, W198, W202

Psychotomimetic effects W223

Psychotropic Medications M181, W66

Psyichiatric Disorders W208

Puberty M43

Publication Bias T211

Pupillometry W27

Purine T266

Pyramidal Cell M177

Pyramidal Neuron W54

Quantitative EEG M36

Quantitative Electroencephalography (qEEG) M149, T136

R-(-)-Ketamine W131, W133

Racemic Ketamine and metabolites M119, M128, W133

Racial Ethnic Minority M137

Raclopride T243

Raman Spectroscopy T209

Randomized Double-Blind M55

Rapamycin T82

Rapastinel M124, M269, W84

Rapid Antidepressant 20.1, W84

Rapid Antidepressant Effects 34.4

Rapid Depression Treatment M123

Rapid-Acting Antidepressant M124

Rare Disorders 33

Rare Variation T123

Rat T110

Rat models 9.2, M230

Rater Reliability W88

Rating Scales W46, W143

Readmission risk T208

Real-Time fMRI Neurofeedback 17, 17.3, M87

Reappraisal T73

Recent Onset Psychosis T203

Receptor Heteromerization T231

Receptor Internalization Trafficking, M239

Receptor Occupancy W113

Reciprocity T93

Recovery Definition W213

Recruitment 22

Regulatory 58.2

Regulatory Policy 21

Reinforcement M282, T264

Reinforcement learning T21, T89, T142, W190

Reinforcement-based decision-making W238

Reinstatement 50.4, T223, T224

Relapse T113, W232

Relapse and Treatment Outcome 18.1

Relapse Biomarkers M208, M252, T55

Remifentanil M276

Remote Memory T3

Repastinel 34.2

Repetitive Transcranial Magnetic Stimulation (rTMS) M47, T273

Replication M127

Reproducibility M127

Research Domain Criteria (RDoC) M155, T23, W94

Resilience M25, M161, T150

Respiration T10

Response Inhibition T16, T261, W34

Resting State T186

Resting State fMRI 2.3, 39.1, M79, M80, M97, M100, M136, M230, M248, M257, T25, T77, T90

Resting State Functional Connectivity M27, M36, M43, M101, M102, M136, M158, M164, M208, M231, M255, T35, T54, T56, T67, T74, T76, T92, T98, T152, T186, T197, T204, W12, W58, W109

Resting State Networks M96

RET biosensors W278

Retention 22

Retina W86

Rett Syndrome W48

Reversal Learning M30, W70

Reward 19.4, 41, M66, T54, T62, T265, W61, W155, W190

Reward and Aversion 16.4, 41.3, W168

Reward Circuitry 15.3, 45.2, M88, T176

Reward Functioning T152

Reward Learning T22, T64

Reward Neural Circuitry 35

Reward Processing M31, T190

Reward Self-Administration W232

Reward Sensitivity M65

Reward-Based Decision-Making M64, M194

Rhesus M8

Ribosome Profiling M205

Right Temporo-Parietal Junction M207

Risk 24.4, T94

Risk and Resilience M88, T17, T227

Risk Factors W214

Risk for Social Anxiety Disorder M17

Risk-Taking M81

Risky Decision-Making 41.3, M33, M245, M254, T239, T276

RMTg M141, W237

RNA Sequencing 44, 44.4, M143, T33, T206, T235, W78, W244

RNA Splicing 44.3

RNAscope Fluorescence in Situ Hybridization T182, T207

RNA-seq M30, M61

Rodents 19

Safety M55, M118, W51, W221

Salience Network M259, T89

Samidorphan W85, W136

Satiation W61

Schizophrenia 11.3, 12.2, 12.4, 25, 25.3, 25.4, 26.1, 29.1, 29.4, 32, 38, 43.2, 43.4, 49, 49.4, 58.1, 58.3, M172, M176, M177, M178, M180, M184, M185, M188, M196, M197, M201, M202, M206, M207, M210, M215, M216, M217, T40, T42, T43, T44, T46, T179, T183, T188, T191, T193, T196, T201, T202, T210, T212, T213, W36, W182, W184, W186, W193, W195, W197, W200, W214, W221, W222, W224

Schizophrenia Genetics M179, W194

Schizophrenia Negative Symptoms T45

Schizophrenia Novel Treatment M183, M186, M190, T184, T185, T187, T189, T213, W183, W187, W219

Schizophrenia Spectrum Disorders 56.3

Schizophrenia Subtypes 25, W217

Schizophrenia-like Behavior 49.3, M222, T218

Schizotypal Personality Disorder W195

Schizotypy W195

Schnurri-2 Knockout Mice W180

Screening 7.1

Seasonal Affective Disorder M68

Seizures 21, T160

Self-Administration M225, M269, T278, T267, W229, W234, W237, W274

Self-Efficacy M81

Self-Injurious Behavior M162

Self-Referential W269

Semantic W166

Senescence Associated Secretory Phenotype W1

Sensitive Period W149

Sensitization M240

Sequencing 11.3, M202

Sequential Parallel Clinical Design T138

Serious Mental Illness T196

Serotonergic System T28

Serotonin M6, M111, M157, M284, T106, W139, W149

Serotonin 1A Receptor M284, T155, W28

Serotonin 5-HT2A Receptor M226

Serotonin 5-HT2C Receptor 50, M239, W275

Serotonin And Norepinephrine Reuptake Inhibitor M103, W69

Serve And Return T93

Sex M89

Sex Differences 53.3, M9, M43, M110, M127, M128, M134, W138, W258, M281, T33, T60, T83, T111, T147, T151, T165, T218, T267, T274, W5, W30, W57, W59, W76, W132, W164, W229, W234, W272, W274, W280, W281

Sex Hormones M128, T23, W122, W280

Sex Steroids T112

Shared Emotional Affect 9

Short-Term Clinical Studies M183

Signal Transduction W181

Signaling Networks 43.1, M51

Sign-Tracking 6.3

Simulated Driving M256

Simultaneous PET-MR W145

Single-cell RNA sequencing 52.3, W8, W182, W261

Single-Cell Sequencing 52, 52.4

Single-Nucleus T206

Skin Conductance Responses 48.2, T5, W21

SLC39A8 M179

Sleep 1, 10.2, M36, M78, T219, W86, W142

Sleep Deprivation M36

Sleep Disturbance 1.3, M31, T158

Sleep-Dependent Learning T193

Slow Wave Activity 10.2

Slow Wave Sleep 10.2, 10.4

Slow-Wave Sleep 10

Smartphone-Based App M82

Smoking T237

Smoking Cessation W251

SNP M239, T197

Social M131

Social Anxiety T88, W13, W32

Social Anxiety Disorder M254

Social Behavior 37, 37.2, 48.4, M30, M163, T57, T83, W24, W50, W228

Social Cognition 56.2, 56.3, M188, M191, T24, W121, W256, W257

Social Defeat Stress 1.1, M28, M66, M73, T102, T225

Social Function 56

Social Functioning W32

Social Processing 33.1

Social Reward M17, M254, W13

Social Status W28

Social Stimuli M254

Social Stress Buffering M5

Social Withdrawal M220

Soluble Epoxide Hydrolase T99

Somatomotor W158

Somatosensory Network T101

Somatosensory Processing W24

Somatostatin 40.1, M223

Spatial Memory M45

Spinogenesis 16.3

State Dependence W158

Stem Cells W36

STG M206

Stimulant Dependence M231

Stopping T16

Stress 34.2, 52.3, M69, M129, T150, W76

Stress Models T14, T275

Stress Reactivity 15.3, M39, M244

Stress Resilience T3

Stress Response Circuitry M110

Stress-Immune Dysregulation W57

Stress-Induce Psychopathologies 52.3

Striatal Pathways M208

Striatum 7.2, T64, T280

Structural MRI 19.2, 25.2, 25.3, M19, T38, T242, W107, W114, W203

Structural Neuroimaging 24.4, 39.2, W111

Structure Of Psychopathology 39.4

Subcallosal Cingulate M80

Subcortical Shape Analysis M58, T104

Subgenual Cingulate Cortex T133, T206

Subjective Cognitive Decline W2

Subjective Cognitive Impairment W2

Subjective Response W276

Substance Abuse M241, M283

Substance Abuse Disorders 53, T249, W139

Substance Use Disorder M266

Subtypes 25.2

Suicidal Behavior W173, W214

Suicidal Ideation M14, T118

Suicidal Ideation And Behavior Assessment Tool W88

Suicidality M48, T140, W103, W134

Suicide 4, 4.1, 4.2, M61, M70, M86, M89, M113, T23, T25, T122, W93

Suicide Assessment 4.3, W93

Suicide Prediction M101, W73

Support Vector Machine (SVM) T57, W107

susceptibility T150

Sustained Antidepressant T148

Sustained Remission T141

Sympathetic Nervous System W124

Symptomatology M100

Symptoms M185, W215

Synapse 26.1, 34.2, 43, 49, 49.3

Synaptic Aberrations 12.4, 43.4, 49.4

Synaptic Density M75, T256

Synaptic Organizers W174

Synaptic Plasicity W147

Synaptic Plasticity 19.3, 27, 27.2, 27.3, 31.3, 41.2, 43.4, T49, T270, W243

Synaptic Protein Interaction Networks W174

Synchrony T150

Synthetic Opioids 50.2

Synthetic Psychoactive Cathinones M233

TAK-653 M148

Tardive Dyskinesia T170, T171

Target Engagement 12.2, W185, W189

Targeted 38

Targeted Cognitive Training T183

Task-Based Functional Connectivity 54.3, M259, T26, T195, W275

Taste M57, W63

TDCS W185

TDP-43 T126

Technology 58.3

Telemedicine T164

Teletherapy T164

Telomere M86

Temperament M114, M227, W217

Temperature Regulation M140

Testosterone W67

tGSH W200

Thalamus T260, T283

THC M267, T54, T215, T263, W237, W261

Theory of Mind M207

Theta 36, M193, W191

Theta Burst Transcranial Magnetic Stimulation W12

THIK1 M277

Thorough QT study M118

Threat 48

Threat Conditioning 3.3, 48.3

Threat Faces M24, M191

Threat of Shock T240

Thyroid Hormone M22

Tic Disorders M47

Timing T163

Titi Monkey 37

TMS M3, M149, T55, T261, W141

TMS EEG T153

TMS Targeting M3

TMS-EEG W227

TNF-alpha M219

Tobacco W267

Tobacco Smoking M248, W251

Tolerance M226

Toll-Like receptors (TLRs) M60, M242

Top-Down Control M24

Touchscreen T121

Tourette syndrome M47

Toxins M144

Toxoplasma W216

Tract Tracing W75

Transcranial Direct Current Stimulation M213

Transcranial Magnetic Stimulation T137, T172

Transcription Factor M73

Transcription Imputation M18

Transcriptional Profiling W244

Transcriptome 11.1, T135, T162

Transcriptomics 7.2, 33.4, 52, 52.4, M238

transcutaneous auricular vagus nerve stimulation (taVNS) M110

Transdiagnostic T137

Transdifferentiation W212

Transgenic Mice 1.3

Transient receptor potential (TRP) A1 M140

Translational Approaches To Drug Development 12

Translational Biomarker Development M52

Translational Neuroscience 6.3, 40, T68

Translational Research 6, 14, 27, W7

Translocator Protein T44

Trauma W16

Trauma Exposure T196, W19

Traumatic Brain Injury (TBI) M92, M113, M153, M283, T254, W176

Traumatic Memories M22

Treatment 29, M78, W33

Treatment Access T134

Treatment Markers 2.4

Treatment Outcome Prediction W17

treatment resistant T144

treatment resistant cohort M115

Treatment Resistant Depression M84, M106, M148, T115, T116, T128, W89, W98

treatment response T84

Treatment-Naive T247

Treatment-Response 2, M203, W205

Tretment Response M182

Trichotillomania W72

TSPO T246

TSPO and [11C]PBR-28 PET T254

Twins W196

Two Photon Microscopy 40.4, 45.2

Two-Photon 16.1, T39

Ubiquitination M176

Uncertainty 3.2, 3.4

Unconditioned Responses T5

Vaccine Immunotherapy 50

Vagus M112

Valbenazine T170, T171

Validation W88

Valproic Acid T82

Vapor M232

Varenicline M246

Vascular W114

Vasopressin 1A Receptor Antagonist W74

Ventral Hippocampus T155, W70

Ventral Pallidum 41.1

Ventral Striatum M209

Ventral Tegmental Area (VTA) M62, M64, M105, M123, M126, M277, T277, W35, W244

Ventromedial Prefrontal Cortex T272

Verbal Episodic Memory M192

Veterans M92, W172

Vicarious Learning 48.3

Virtual Reality 16, 16.1, 16.2

Visceral Obesity W199

Visual W176

Visual Attention T90

Visual Cortex T87

Visual Information Processing W11

Visual Memory T90

Visual Perception M24

Visuospatial Ability M164

Visuospatial Working Memory T182, T190

Voltage-Gated Calcium Channel M146, T217, W218

Voltammetry W284

Volume T199

Voxel-Based Morphometry (VBM) W40, W235, W257

VTA T279

Vulnerability T110, W234, W238

Vulnerability Traits W262

Weight Gain W220

Wellbeing W126

White Matter M95

White Matter Integrity W118

White Matter Neurons 10.4

Whole Exome Sequencing M132

Whole Genome Sequencing W192

Whole-Brain Rodent Imaging T68

Whole-Genome 11.3, M202

Williams Syndrome 33.3, M41

Withdrawal M270, M273, T43, T226

Within Person Variance 32

Wnt Signaling W83

Women's Mental Health T23, T74, T145

Word Embedding Clustering W166

Workforce 22

Working Memory 40.1, M3, M171, M192, M223, T26, T195, T261, W5, W159, W191, W218, W277

World Trade Center Responders W20

Worry T73

Young Adults W34

Youth 24.4, 48.3, 54.4, W106

β-arrestin 43.3